R3(BΔ23-27)R/I5 chimeric peptide   Click here for help

GtoPdb Ligand ID: 3907

Comment: Synthetic chimeric peptide consisting of the A chain of human INSL5 linked via cysteine bonds to a synthetic analogue of the human relaxin 3 B chain. The two subunit components are linked by disulphide bonds between cysteine residues. The sequence of the relaxin 3 component is shown via the link in the structure tab; for the sequence of the other subunit see INSL5 (A chain).
Click here for help
References
1. Haugaard-Kedström LM, Shabanpoor F, Hossain MA, Clark RJ, Ryan PJ, Craik DJ, Gundlach AL, Wade JD, Bathgate RA, Rosengren KJ. (2011)
Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
J Am Chem Soc, 133 (13): 4965-74. [PMID:21384867]
2. Kocan M, Sarwar M, Hossain MA, Wade JD, Summers RJ. (2014)
Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Br J Pharmacol, 171 (11): 2827-41. [PMID:24641548]
3. Kristensson L, Mayer G, Ploj K, Wetterlund M, Arlbrandt S, Björquist A, Wissing BM, Castaldo M, Larsson N. (2015)
Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Eur J Pharmacol, 747: 123-31. [PMID:25496752]
4. Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, Nepomuceno D, Wu J, Chen J, Kamme F et al.. (2007)
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
J Biol Chem, 282 (35): 25425-35. [PMID:17606621]